3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
46
Breast Neoplasms
9
Salivary Gland Neoplasms
2
Prostate Adenocarcinoma
2
Neoplasm Metastasis
2
Breast Neoplasms, Male
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
Salivary Gland Neoplasm Duct
1
Primary Dysautonomias
1
Patient Compliance
1
PSA Level Greater Than Two
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia
1
Kidney Diseases
1
Hypertension
1
Hormone Sensitive Prostate Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
HER2-positive Breast Cancer
1
Granulosa cell tumor of the ovary
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Interventions
pembrolizumab
137
Nivolumab
116
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Leuprolide
×
1 year
×
Clear all
No trials found.